
OPKO Health OPK
$ 1.35
-2.54%
Quarterly report 2025-Q2
added 07-31-2025
OPKO Health Cash Conversion Cycle 2011-2025 | OPK
Annual Cash Conversion Cycle OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 242 | 253 | 73.3 | 56.1 | 53.5 | 58 | 56.6 | 49.3 | 70.9 | 104 | 152 | 153 | 341 | 342 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 342 | 49.3 | 143 |
Quarterly Cash Conversion Cycle OPKO Health
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63 | 62.2 | 55.7 | 42.4 | 56.8 | 83.9 | 57.1 | 47.8 | - | 31.3 | 31.3 | 65.5 | 58.5 | 61.6 | 60.5 | 50.8 | 52.8 | 61 | 86.7 | 90.8 | 54.8 | 53.7 | 54.3 | 57.1 | 59.2 | 52.6 | 49.8 | 55.4 | 93.8 | 61.4 | 51.6 | 66.1 | 81.4 | 67.4 | 56.3 | 64.9 | 64 | 124 | 209 | 214 | 71.4 | 157 | 134 | 128 | 87.2 | 123 | 108 | 124 | 119 | 311 | 357 | 363 | 198 | 360 | 293 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 363 | 31.3 | 105 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 15.82 | 0.44 % | $ 170 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
225 | $ 1.55 | -4.63 % | $ 1.97 M | ||
|
DarioHealth Corp.
DRIO
|
207 | $ 12.14 | 2.1 % | $ 344 M | ||
|
DexCom
DXCM
|
133 | $ 65.83 | -1.69 % | $ 25.4 B | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 39.06 | 1.11 % | $ 1.08 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Exact Sciences Corporation
EXAS
|
130 | $ 101.64 | 0.14 % | $ 18.8 B | ||
|
Danaher Corporation
DHR
|
83.5 | $ 227.72 | 0.54 % | $ 166 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 27.0 | -0.52 % | $ 816 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 19.98 | -2.82 % | $ 1.07 B | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
385 | $ 3.3 | -7.82 % | $ 105 K | ||
|
Co-Diagnostics
CODX
|
299 | $ 0.29 | -14.47 % | $ 8.51 M | ||
|
IQVIA Holdings
IQV
|
78 | $ 222.75 | 0.24 % | $ 40.4 B | ||
|
Guardant Health
GH
|
49.1 | $ 103.7 | 1.6 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
142 | $ 134.4 | -0.35 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 197.62 | 2.4 % | $ 10.2 B | ||
|
Quotient Limited
QTNT
|
345 | - | -11.32 % | $ 1.1 M | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 410.02 | 1.15 % | $ 29.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
38.6 | $ 183.96 | 0.79 % | $ 20.4 B | ||
|
NeoGenomics
NEO
|
82.3 | $ 12.03 | 1.48 % | $ 1.52 B | ||
|
Neogen Corporation
NEOG
|
150 | $ 6.85 | -0.22 % | $ 1.49 B | ||
|
Biodesix
BDSX
|
41.7 | $ 7.63 | -2.8 % | $ 989 M | ||
|
Myriad Genetics
MYGN
|
45.1 | $ 7.04 | -2.36 % | $ 638 M | ||
|
Laboratory Corporation of America Holdings
LH
|
39.8 | $ 262.89 | -0.48 % | $ 22.1 B | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 184.38 | -1.18 % | $ 15.2 B | ||
|
IDEXX Laboratories
IDXX
|
108 | $ 698.77 | -0.77 % | $ 57.6 B | ||
|
Lantheus Holdings
LNTH
|
90.9 | $ 66.4 | -0.33 % | $ 4.59 B | ||
|
Agilent Technologies
A
|
111 | $ 140.3 | 0.46 % | $ 42.7 B | ||
|
Biomerica
BMRA
|
172 | $ 2.48 | -2.65 % | $ 5.7 M | ||
|
Bioventus
BVS
|
208 | $ 7.49 | -0.86 % | $ 469 M | ||
|
Pacific Biosciences of California
PACB
|
149 | $ 2.13 | 0.24 % | $ 540 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K |